Market Tracker

11/17 5:15pm ET

BioDelivery Sciences International Inc (NASDAQ:BDSI)

2.25
Delayed Data
As of Nov 17
 0.00 / 0.00%
Today’s Change
1.50
Today|||52-Week Range
3.60
+28.57%
Year-to-Date
5 Small Biotechs Receive Shots in the Arm
Nov 12 / TheStreet.com - Paid Partner Content
BioDelivery (BDSI) Q3 Earnings, Sales Beat Estimates
Nov 10 / Zacks.com - Paid Partner Content
Endo (ENDP) Earnings & Revenues Beat in Q3, Generics Weak
Nov 10 / Zacks.com - Paid Partner Content
BioDelivery (BDSI) to Report Q3 Earnings: What's in Store?
Nov 07 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close2.25
Today’s open2.30
Day’s range2.05 - 2.30
Volume640,802
Average volume (3 months)533,062
Market cap$125.7M
Dividend yield--
Data as of 4:00pm ET, 11/17/2017

Growth & Valuation

Earnings growth (last year)-73.61%
Earnings growth (this year)+109.07%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)-67.77%
P/E ratio25.0
Price/Sales6.04
Price/Book--

Competitors

 Today’s
change
Today’s
% change
OMEDOncoMed Pharmaceutic...0.000.00%
OCXOncoCyte Corp0.000.00%
MNKDMannKind Corp0.000.00%
CLSDClearside Biomedical...0.000.00%
Data as of 8:00pm ET, 11/17/2017

Financials

Next reporting dateMarch 19, 2018
EPS forecast (this quarter)-$0.23
Annual revenue (last year)$15.5M
Annual profit (last year)-$67.1M
Net profit margin-431.87%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Vice Chairman, President &
Chief Executive Officer
Mark A. Sirgo
CFO, Principal Accounting Officer &
Secretary
Ernest R. de Paolantonio
Corporate headquarters
Raleigh, North Carolina

Forecasts